Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein

Duško Lainšček(National Institute of Chemistry), Roman Jerala(National Institute of Chemistry), Sara Orehek(University of Ljubljana), David Peterhoff(Institute of Medical Microbiology and Hygiene), Sara Vidmar(University of Ljubljana), Peter Pečan(University of Ljubljana), Gregor Anderluh(National Institute of Chemistry), Tina Fink(National Institute of Chemistry), Tjaša Plaper(University of Ljubljana), Hana Esih(University of Ljubljana), Mojca Benčina(National Institute of Chemistry), Neža Omersa(National Institute of Chemistry), Florence Pojer(École Polytechnique Fédérale de Lausanne), Bruno E. Correia(SIB Swiss Institute of Bioinformatics), Mateja Manček‐Keber(EN-FIST Centre of Excellence (Slovenia)), Iva Hafner‐Bratkovič(University of Ljubljana), David L. Hacker(École Polytechnique Fédérale de Lausanne), Jana Aupič(National Institute of Chemistry), Kelvin Lau(École Polytechnique Fédérale de Lausanne), Špela Malenšek(University of Ljubljana), Lucija Kadunc(University of Ljubljana), Žiga Strmšek(University of Ljubljana), Vida Forstnerič(National Institute of Chemistry), Ralf Wagner(Paul Ehrlich Institut), Petra Dekleva(University of Ljubljana)
bioRxiv (Cold Spring Harbor Laboratory)
August 28, 2020
Cited by 10


Related Papers